Developer docs
API playgroundTry for free, no card

Search company profiles

Cannovum

Full company profile

uuid002nrw4

Namestring
Cannovum
Legal namestring
CANNOVUM CANNABIS AG
Websiteurl
cannovum.com
Company typeenum
Public
Founded yearint
2018
Descriptiontext

Cannovum AG is a Berlin-headquartered, publicly traded pharmaceutical company (Aktiengesellschaft) founded in 2018 that imports and distributes cannabis-based medicines in the German market. The company is registered in the Frankfurt/Main commercial register (HRB 119297) and operates from Stresemannstraße 23 in Berlin. It was constituted from inception as a stock-exchange-traded public limited company (börsengehandelte Aktiengesellschaft), with Alexander Landgraf-Meltzer serving as the sole executive board member (Vorstand) and concurrently as Data Protection Officer (Datenschutzbeauftragter).

The company employs between 11 and 50 people per firmographic data. The source material is highly limited with respect to product portfolio, technology stack, pricing, distribution channels, customer segments, and go-to-market motion — these are explicitly listed as "Not disclosed in available sources." The company's public website (cannovum.com) consists almost entirely of corporate identity, contact, and German-language legal/privacy notices; there is no named product line, platform architecture, or technology component described in the provided data. A separate investor relations site (ir.cannovum.com) is referenced, consistent with its listed-company status.

From a capital-structure standpoint, Cannovum is described as a public stock corporation with no disclosed parent company, no documented subsidiaries, and no private equity or venture capital ownership signals identified in the source material. Financial table values included in the input are not internally consistent with a 11–50 employee specialty pharmaceutical distributor and are treated as unreliable data artifacts rather than reported figures; the company's actual revenue, profitability, and cash position are not credibly disclosed in the available material.

Short descriptiontext

Cannovum AG is a Berlin-based, publicly traded pharmaceutical company (Aktiengesellschaft) that imports and distributes cannabis-based medicines in Germany, operating since 2018 as a stock-exchange-listed entity.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersBielefeld, Germany
HQ citystring
Bielefeld
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical cannabis distribution, pharmaceutical imports, cannabis-based medicines, pharmaceutical wholesale, cannabis pharmaceuticals
SIC code2 codes
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
  • Pharmaceutical Preparations2834
Product category
Pharmaceutical Distribution
Social media profiles2 records
Cost components4 values
Supply Chain, Operations, Personnel, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Cannovum (legally CANNOVUM CANNABIS AG) is a Berlin-based pharmaceutical company that imports and distributes cannabis-based medicines in Germany. Founded in 2018 as a stock-exchange traded Aktiengesellschaft, the company operates as a pharmaceutical importer and distributor focused on medical cannabis products for the German healthcare market.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Based on the available source data, CANNOVUM AG is a publicly listed stock corporation (Aktiengesellschaft) incorporated in 2018 and headquartered in Berlin, Germany. The source material does not contain specific details about the company's product or service offerings, product portfolio, or technology platform. The scraped content is limited to corporate identity information, investor relations pages, contact details, and legal/privacy notices. No named products, modules, or services are described in the provided data.

Product and service1 record
1Cannabis-based medicines
CategoryMedical cannabis pharmaceuticals
Description

Imported and distributed cannabis-based pharmaceutical products supplied to pharmacies, hospitals, and healthcare professionals in Germany.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Recent move2 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight1 record

Each record includes

Type, Description

Peers9 records
TypeBroad incumbent
Description

Canadian-listed global cannabis operator active across European medical markets including Germany. Comparable medical cannabis category, but operating at materially larger scale and breadth than Cannovum.

TypeDirect peer
Description

German medical cannabis cultivator, manufacturer and wholesaler. Comparable vertically integrated business serving the same German medical cannabis patient base as Cannovum.

TypeBroad incumbent
Description

Large Canadian cannabis producer with European operations targeting Germany's medical market. Comparable medical cannabis category and German-channel ambitions, but at substantially larger and broader scale.

TypeDirect peer
Description

German medical cannabis importer and distributor operating from Frankfurt. Directly comparable to Cannovum on product category (medical cannabis), market (Germany), and business model (wholesale distribution to pharmacies).

TypeDirect peer
Description

Berlin-based cannabis healthcare company covering cultivation, distribution and pharma. Comparable German cannabis start-up building end-to-end medical cannabis supply chain.

TypeBroad incumbent
Description

Major German generic pharmaceutical company that has moved into medical cannabis distribution through partnerships. Comparable end-market (German pharmacies) but at vastly broader pharma scale and product breadth.

TypeDirect peer
Description

German medical cannabis importer and distributor serving pharmacies. Closely overlaps Cannovum on wholesale distribution of cannabis-based medicines in Germany under BfArM licensing.

8Tilray Brands Inc.
TypeBroad incumbent
Description

Global cannabis company with strong German medical cannabis distribution presence through Tilray Deutschland. Comparable distribution-to-German-pharmacy model, but at much larger international scale.

9Schwabe Pharma AG & Co. KG
TypeRegional player
Description

Major German phytopharmaceutical company producing plant-based medicines including cannabis-based preparations. Comparable botanical pharmaceutical manufacturing serving German pharmacy channels.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat1 record

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Cannovum

Pharmaceutical Distributioncannovum.com

Cannovum AG is a Berlin-based, publicly traded pharmaceutical company (Aktiengesellschaft) that imports and distributes cannabis-based medicines in Germany, operating since 2018 as a stock-exchange-listed entity.

What Cannovum does

Cannovum AG is a Berlin-headquartered, publicly traded pharmaceutical company (Aktiengesellschaft) founded in 2018 that imports and distributes cannabis-based medicines in the German market. The company is registered in the Frankfurt/Main commercial register (HRB 119297) and operates from Stresemannstraße 23 in Berlin. It was constituted from inception as a stock-exchange-traded public limited company (börsengehandelte Aktiengesellschaft), with Alexander Landgraf-Meltzer serving as the sole executive board member (Vorstand) and concurrently as Data Protection Officer (Datenschutzbeauftragter).

The company employs between 11 and 50 people per firmographic data. The source material is highly limited with respect to product portfolio, technology stack, pricing, distribution channels, customer segments, and go-to-market motion — these are explicitly listed as "Not disclosed in available sources." The company's public website (cannovum.com) consists almost entirely of corporate identity, contact, and German-language legal/privacy notices; there is no named product line, platform architecture, or technology component described in the provided data. A separate investor relations site (ir.cannovum.com) is referenced, consistent with its listed-company status.

From a capital-structure standpoint, Cannovum is described as a public stock corporation with no disclosed parent company, no documented subsidiaries, and no private equity or venture capital ownership signals identified in the source material. Financial table values included in the input are not internally consistent with a 11–50 employee specialty pharmaceutical distributor and are treated as unreliable data artifacts rather than reported figures; the company's actual revenue, profitability, and cash position are not credibly disclosed in the available material.

Cannovum firmographics

Firmographics
Name
Cannovum
Legal name
CANNOVUM CANNABIS AG
Website
https://cannovum.com
Company type
Public
Founded year
2018
Operating status
Operating
Headcount range
1–10 employees
Short description
Cannovum AG is a Berlin-based, publicly traded pharmaceutical company (Aktiengesellschaft) that imports and distributes cannabis-based medicines in Germany, operating since 2018 as a stock-exchange-listed entity.
Ownership category
akta.pro rank

Where Cannovum is headquartered

Location

Headquarters

HQ city
Bielefeld
HQ country
Germany
HQ region
Europe

Offices1 record

Markets served

Cannovum business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Supply Chain, Operations, Personnel, Marketing or Sales

Cannovum product offering

Product offering

Core offering

Cannovum (legally CANNOVUM CANNABIS AG) is a Berlin-based pharmaceutical company that imports and distributes cannabis-based medicines in Germany. Founded in 2018 as a stock-exchange traded Aktiengesellschaft, the company operates as a pharmaceutical importer and distributor focused on medical cannabis products for the German healthcare market.

Product overview

Based on the available source data, CANNOVUM AG is a publicly listed stock corporation (Aktiengesellschaft) incorporated in 2018 and headquartered in Berlin, Germany. The source material does not contain specific details about the company's product or service offerings, product portfolio, or technology platform. The scraped content is limited to corporate identity information, investor relations pages, contact details, and legal/privacy notices. No named products, modules, or services are described in the provided data.

Differentiator

Problem solved

Functional benefit

Products and services

  • Cannabis-based medicines Imported and distributed cannabis-based pharmaceutical products supplied to pharmacies, hospitals, and healthcare professionals in Germany.

Companies that use Cannovum

Customer profile

Ideal customer profiles1 record

Cannovum technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Cannovum partnerships and signals

Strategic signal

Scale indicators1 record

Recent moves2 records

Expansion highlights1 record

Cannovum competitors and assessment

Company assessment

Broad incumbents

  • Canopy Growth Corporation: Canadian-listed global cannabis operator active across European medical markets including Germany. Comparable medical cannabis category, but operating at materially larger scale and breadth than Cannovum.
  • Aurora Cannabis Inc. Large Canadian cannabis producer with European operations targeting Germany's medical market. Comparable medical cannabis category and German-channel ambitions, but at substantially larger and broader scale.
  • Stada Arzneimittel AG: Major German generic pharmaceutical company that has moved into medical cannabis distribution through partnerships. Comparable end-market (German pharmacies) but at vastly broader pharma scale and product breadth.
  • Tilray Brands Inc. Global cannabis company with strong German medical cannabis distribution presence through Tilray Deutschland. Comparable distribution-to-German-pharmacy model, but at much larger international scale.

Direct peers

  • Demecan Holding GmbH: German medical cannabis cultivator, manufacturer and wholesaler. Comparable vertically integrated business serving the same German medical cannabis patient base as Cannovum.
  • Cansativa GmbH: German medical cannabis importer and distributor operating from Frankfurt. Directly comparable to Cannovum on product category (medical cannabis), market (Germany), and business model (wholesale distribution to pharmacies).
  • Sanity Group GmbH: Berlin-based cannabis healthcare company covering cultivation, distribution and pharma. Comparable German cannabis start-up building end-to-end medical cannabis supply chain.
  • Nimbus Health GmbH: German medical cannabis importer and distributor serving pharmacies. Closely overlaps Cannovum on wholesale distribution of cannabis-based medicines in Germany under BfArM licensing.

Regional players

  • Schwabe Pharma AG & Co. KG: Major German phytopharmaceutical company producing plant-based medicines including cannabis-based preparations. Comparable botanical pharmaceutical manufacturing serving German pharmacy channels.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat1 record

Key risks5 records

Key highlights5 records

Customer concentration

Cannovum social profiles

Digital presence

Cannovum financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Cannovum leadership team

Management profile

Number of profiles

Profiles1 record

Cannovum funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Cannovum M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cannovum

What does Cannovum do?

Cannovum (legally CANNOVUM CANNABIS AG) is a Berlin-based pharmaceutical company that imports and distributes cannabis-based medicines in Germany. Founded in 2018 as a stock-exchange traded Aktiengesellschaft, the company operates as a pharmaceutical importer and distributor focused on medical cannabis products for the German healthcare market.

Is Cannovum a public or private company?

Cannovum is a public company. It is classified as unknown and is currently operating.

When was Cannovum founded?

Cannovum was founded in 2018. It employs 1 to 10 people.

Where is Cannovum based?

Cannovum is headquartered in Bielefeld, Germany, in the Europe region.

Who are Cannovum's main competitors?

Broad incumbents on record are Canopy Growth Corporation, Aurora Cannabis Inc., Stada Arzneimittel AG and Tilray Brands Inc.. Direct peers are Demecan Holding GmbH, Cansativa GmbH, Sanity Group GmbH and Nimbus Health GmbH. Schwabe Pharma AG & Co. KG is listed as a regional player.

Does Cannovum have an API?

No public API is recorded for Cannovum.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals